Pharmaceutical Industry Blog

Leronlimab is a humanized monoclonal antibody designed to target the CCR5 receptor on T cells. This innovative therapy aims to harness...

Mogamulizumab is a humanized monoclonal antibody designed to treat certain types of cancer by targeting the CC chemokine receptor 4...

Vilobelimab is a novel monoclonal antibody designed to treat complement-mediated diseases by targeting the complement component C5. This...

Pozelimab is a novel monoclonal antibody designed to treat complement-mediated diseases by targeting the complement component C5. This...

Crovalimab is a novel monoclonal antibody designed to treat complement-mediated diseases by targeting the complement component C5. This...

Sutimlimab is a monoclonal antibody designed to treat cold agglutinin disease (CAD), a rare autoimmune condition where the immune system...